1. Home
  2. BIP vs PODD Comparison

BIP vs PODD Comparison

Compare BIP & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brookfield Infrastructure Partners LP

BIP

Brookfield Infrastructure Partners LP

HOLD

Current Price

$34.60

Market Cap

16.3B

ML Signal

HOLD

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$159.23

Market Cap

17.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIP
PODD
Founded
2007
2000
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.3B
17.0B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
BIP
PODD
Price
$34.60
$159.23
Analyst Decision
Buy
Buy
Analyst Count
4
21
Target Price
$39.50
$341.48
AVG Volume (30 Days)
768.1K
763.3K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
5.15%
N/A
EPS Growth
N/A
N/A
EPS
N/A
3.48
Revenue
N/A
$2,708,100,000.00
Revenue This Year
N/A
$24.55
Revenue Next Year
$7.61
$19.18
P/E Ratio
$39.22
$52.54
Revenue Growth
N/A
30.73
52 Week Low
$29.19
$182.25
52 Week High
$40.32
$354.88

Technical Indicators

Market Signals
Indicator
BIP
PODD
Relative Strength Index (RSI) 35.24 13.91
Support Level $34.69 N/A
Resistance Level $35.23 $205.95
Average True Range (ATR) 0.85 6.67
MACD -0.12 -1.78
Stochastic Oscillator 32.02 5.49

Price Performance

Historical Comparison
BIP
PODD

About BIP Brookfield Infrastructure Partners LP

Brookfield Infrastructure Partners LP is a Bermuda exempted limited partnership that owns and operates quality, long-life assets that generate stable cash flows, by virtue of barriers to entry or other characteristics that tend to appreciate in value over time. It focuses on acquiring infrastructure assets that have low maintenance capital costs and high barriers to entry. The company's segments consist of Utilities, Transport, Midstream, and Data. Geographically, it generates maximum revenue from USA and also has a presence in Australia, Colombia, United Kingdom, Brazil, United States of America, Chile, Peru, and other countries.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: